DavidNaftaliAdlerMD

PubMed

• Use of Paliperidone in Elderly Patients With Schizophrenia and Schizoaffective Disorder: A Prospective Open-Label Short-Term Pilot Study.
  Madhusoodanan, S., Brenner, R., Serper, M.R., Adelsky, M., Adler, D.N.> ;J Clin Psychopharmacol. 2011 Jun
• Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity.
  Friedman, J.I., Harvey, P.D., McGurk, S.R., White, L., Parrella, M., Raykov, T., Coleman, T., Adler, D.N., Davis, K.L.> ;Am J Psychiatry. 2002 Aug
• A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
  Friedman, J.I., Adler, D.N., Howanitz, E., Harvey, P.D., Brenner, G., Temporini, H., White, L., Parrella, M., Davis, K.L.> ;Biol Psychiatry. 2002 Mar 1
• Guanfacine treatment of cognitive impairment in schizophrenia.
  Friedman, J. I., Adler, D. N., Temporini, H. D., Kemether, E., Harvey, P. D., White, L., Parrella, M., Davis, K. L.> ;Neuropsychopharmacology. 2001 Sep
• The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheim...
  Friedman, J. I., Adler, D. N., Davis, K. L.> ;Biol Psychiatry. 1999 Nov 1
• Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy.
  Friedman, J. I., Lindenmayer, J. P., Alcantara, F., Bowler, S., Parak, M., White, L., Iskander, A., Parrella, M., Adler, D. N., Tsopelas, N. D., Tsai, W. Y., Novakovic...> ;Neuropsychopharmacology. 2011 May
• Join now to see all